Clinical Experience with Levonorgestrel Subdermal Implants (Norplant) for Long-Term Contraception

By Cardamakis E.   Georgopoulos N.A.   Pappas A.P.   Fotopoulos A.   Sykiotis G.P.   Tzingounis V.A.  

Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. : 827-834

Adis International

Access to resources Recommend Favorite

Levonorgestrel subdermal implants are highly effective and reasonably well tolerated

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Risks and Benefits, Advantages and Disadvantages of Levonorgestrel-Releasing Contraceptive Implants

By Sivin I.  

Drug Safety, Vol. 26, Iss. 5, 2003-01 ,pp. : 303-335

Adis International

Access to resources Recommend Favorite

Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites

By Santillan R.   Perez-Palacios G.   Reyes M.   Damian-Matsumura P.   Garca G.A.   Grillasca I.   Lemus A.E.  

European Journal of Pharmacology, Vol. 427, Iss. 2, 2001-09 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg: As an Oral Contraceptive

By Wagstaff Antona J.  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2473-2477

Adis International

Access to resources Recommend Favorite